Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-14 5:53 pm Purchase | 2024-09-30 | 13G | Elevai Labs, Inc. Common Stock ELAB | Anson Funds Management LP | 11,205 9.900% | 11,205 (New Position) | Filing History |
2024-10-02 4:01 pm Purchase | 2024-09-24 | 13G | Elevai Labs, Inc. Common Stock ELAB | S.H.N. Financial Investments Ltd. | 15,208 9.990% | 15,208 (New Position) | Filing History |
2024-10-01 4:01 pm Purchase | 2024-09-24 | 13G | Elevai Labs, Inc. Common Stock ELAB | L1 Capital Global Opportunities Master Fund, Ltd. | 15,855 9.990% | 15,855 (New Position) | Filing History |
2024-09-26 6:28 pm Purchase | 2024-09-23 | 13G | Elevai Labs, Inc. Common Stock ELAB | Altium Capital Management LP | 28,571 9.990% | 28,571 (New Position) | Filing History |
2024-08-16 10:01 am Purchase | 2024-08-15 | 13G | Elevai Labs, Inc. Common Stock ELAB | Santorio Biomedical, LLC | 6,125 5.900% | 6,125 (New Position) | Filing History |
2024-05-31 8:10 pm Purchase | 2024-05-07 | 13G | Elevai Labs, Inc. Common Stock ELAB | MOA LIFE PLUS CO. LTD. | 4,750 5.030% | 4,750 (New Position) | Filing History |
2024-02-21 10:57 am Purchase | 2023-11-13 | 13D | Elevai Labs, Inc. Common Stock ELAB | Braeden Lichti | 19,120 22.070% | 19,120 (New Position) | Filing History |
2024-02-14 09:30 am Purchase | 2023-01-31 | 13G | Elevai Labs, Inc. Common Stock ELAB | Abou-Sayed Hatem | 7,589 8.700% | 7,589 (New Position) | Filing History |
2024-02-14 09:30 am Purchase | 2023-01-31 | 13G | Elevai Labs, Inc. Common Stock ELAB | Hatem Abou-Sayed MD MBA FACS a Professional Medical Corp | 6,860 7.900% | 6,860 (New Position) | Filing History |
2024-02-14 09:30 am Purchase | 2023-01-31 | 13G | Elevai Labs, Inc. Common Stock ELAB | Plews Jordan R. | 14,986 17.000% | 14,986 (New Position) | Filing History |
2024-02-14 09:30 am Purchase | 2023-01-31 | 13G | Elevai Labs, Inc. Common Stock ELAB | JP Bio Consulting LLC | 14,257 16.500% | 14,257 (New Position) | Filing History |